Click here for a downloadable word document of the shared care agreement forms:
Denosumab 60mg injection - Treatment of osteoporosis in postmenopausal women and in men at increased risk of fracture and treatment of bone loss
associated with long-term systemic glucocorticoid therapy in adult patients at increased risk of fracture
For hypogonadism due to testosterone deficiency in adult men
Indication (licensed):Testosterone replacement therapy for male hypogonadism when testosterone deficiency has been confirmed by clinical features and biochemical tests.
Unlicensed indication: As supplementation for postmenopausal women with low sexual desire if HRT alone is not effective.
Further patient information is available via the RCOG menopause hub: https://www.rcog.org.uk/for-the-public/menopause-and-later-life/
British Menopause Society – testosterone factsheet